Separate reporting of clinical acute rejection and subclinical acute rejections in kidney transplantation [3]

Transplantation

Volumn 82, Issue 11, 2006, Pages 1551-1552

  Kumar, Mysore S Anil ^a,b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b MS 417   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; METHYLPREDNISOLONE; STEROID; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; CHRONIC ALLOGRAFT NEPHROPATHY; DRUG WITHDRAWAL; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DYSFUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; MAINTENANCE THERAPY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SUBACUTE GRAFT REJECTION; TREATMENT OUTCOME;

EID: 33845711462     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000237223.69828.3e     Document Type: Letter

References (9)

1. Nankivell BL, Borrows RJ, Fung CLS, et al. Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation 2004; 78: 242.
2. Choi BS, Shin MJ, Shin SJ, et al. Clinical significance of an early protocol biopsy in living-donor renal transplantation: Ten year experience at a single center. Am J Transplant 2005; 5: 1354.
3. Miyagi M, Ishikawa Y, Mizuiri S, et al. significance of subclinical rejection in early allograft biopsies for chronic allograft dysfunction. Clin Transplant 2005; 19(4): 456.
4. Rush DN, Jeffery JR, Gough J, et al. sequential protocol biopsies in renal transplant patients. Clinico-pathological correlations using the Banff schema. Transplantation 1995; 59: 511.
5. Kumar MSA, Moritz MJ, Saaed MI, et al. Avoidance of chronic steroid therapy in African American kidney transplant recipients monitored by surveillance biopsy: 1-year results. Am J Transplant 2005; 5: 1976.
6. Kumar MSA, Heifets M, Fyfe B, et al. Comparison of steroid avoidance in tacrolimus/mycophenolate mofetil and Tacrolimus/sirolimus combination in kidney transplantation monitored by surveillance biopsy. Transplantation 2005; 80: 807.
7. Rush DN, Nickerson P, Gough J, et al. beneficial effects of treatment of early subclinical rejection: a randomized study. J Am Soc Nephrol 1998; 9: 2129.
8. Haririan A, Sillix DH, Morawski K, et al. Short-term experience with early steroid withdrawal in African-American renal transplant recipients. Am J Transplant 2006; 6: 2396.
9. Gruber SA, West MS, Sillix DH, et al. preliminary results with early corticosteroid withdrawal in African American renal allograft recipients. Surgery 2005; 138: 772.